Biogen (BIIB)
(Delayed Data from NSDQ)
$204.76 USD
-0.06 (-0.03%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $204.61 -0.15 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 3.82 |
EPS Last Quarter | 5.28 |
Last EPS Surprise | 32.00% |
ABR | 1.67 |
Earnings ESP
|
-0.11% |
---|---|
Current Year | 16.08 |
Next Year | 17.26 |
EPS (TTM) | 16.26 |
P/E (F1) | 12.73 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.43B | 2.45B | 9.64B | 9.54B |
# of Estimates | 23 | 23 | 24 | 24 |
High Estimate | 2.57B | 2.61B | 9.93B | 10.34B |
Low Estimate | 2.25B | 2.26B | 9.41B | 8.89B |
Year ago Sales | 2.53B | 2.39B | 9.84B | 9.64B |
Year over Year Growth Est. | -3.96% | 2.74% | -1.99% | -1.03% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.82 | 3.42 | 16.08 | 17.26 |
# of Estimates | 22 | 20 | 24 | 24 |
Most Recent Consensus | 3.70 | 3.39 | 16.46 | 16.82 |
High Estimate | 4.45 | 3.87 | 16.87 | 22.44 |
Low Estimate | 3.44 | 2.61 | 15.33 | 13.98 |
Year ago EPS | 4.36 | 2.95 | 14.72 | 16.08 |
Year over Year Growth Est. | -12.39% | 15.93% | 9.24% | 7.31% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 4 | 1 | 20 | 7 |
Up Last 60 Days | 4 | 1 | 19 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 14 | 16 | 1 | 14 |
Down Last 60 Days | 14 | 16 | 2 | 14 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 3.82 | 3.42 | 16.08 | 17.26 |
7 Days Ago | 3.82 | 3.49 | 16.06 | 17.12 |
30 Days Ago | 3.98 | 3.93 | 15.62 | 17.37 |
60 Days Ago | 4.00 | 3.95 | 15.62 | 17.44 |
90 Days Ago | 4.00 | 3.95 | 15.62 | 17.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.82 | 3.40 | 16.12 | 17.24 |
Zacks Consensus Estimate | 3.82 | 3.42 | 16.08 | 17.26 |
Earnings ESP | -0.11% | -0.69% | 0.21% | -0.10% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 5.28 | 3.67 | 2.95 | 4.36 | NA |
Estimate | 4.00 | 3.45 | 3.16 | 3.99 | NA |
Difference | 1.28 | 0.22 | -0.21 | 0.37 | 0.42 |
Surprise | 32.00% | 6.38% | -6.65% | 9.27% | 10.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more